Abstract
To evaluate the effectiveness of ginsenoside Rg3 alone or in combination with cyclophosphamide (CPA) on tumor growth and angiogenesis in human lung cancer, 54 female athymic mice were transplanted with lung cancer cells (A549) which then were randomly divided into 4 groups: Ginsenoside Rg3 group, CPA group, ginsenoside Rg3 plus CPA group and control group. Ginsenoside Rg3 of 3.0 mg/kg (once/day for 10 days) and CPA of 20.0 mg/kg (once/day for 10 days) were intraperitoneally given to mice for consecutive 10 days. Seven mice selected from each group were sacrificed 18 days later. The survival time of the remaining 7 mice in each group was recorded. The life elongation rate, proliferating cell nuclear antigen labeling index (PCNALI), expression of vascular endothelial cell growth factor (VEGF) and microvessel density (MVD) in the tumor tissues were evaluated. The quality of life of mice with administration of ginsenoside Rg3 alone or ginsenoside Rg3 plus CPA were better with longer survival time, when compared with other groups. The PCNALI, MVD and VEGF expression in mice of the treated groups were significantly lowered when compared with that of the control group. Additionally, the MVD of mice in groups with treatment of ginsenoside Rg3 alone or ginsenoside Rg3 plus CPA were lower than that in the CPA group. Tumor growth and angiogenesis in lung cancer were profoundly inhibited by ginsenoside Rg3 alone or in combination with CPA. The synergistic anticancer effects of ginsenoside Rg3 and CPA improved the survival time in lung cancer. Key words: Ginseng, cyclophosphamide, angiogenesis, lung cancer.
Highlights
With the development of Chinese herbal medicine, more and more researchers are interested in the exploitation of novel anticancer components in herbs
To evaluate the effectiveness of ginsenoside Rg3 alone or in combination with cyclophosphamide (CPA) on tumor growth and angiogenesis in human lung cancer, 54 female athymic mice were transplanted with lung cancer cells (A549) which were randomly divided into 4 groups: Ginsenoside Rg3 group, CPA group, ginsenoside Rg3 plus CPA group and control group
The results demonstrate that ginsenoside Rg3 prolonged survival time of mice with lung cancer
Summary
With the development of Chinese herbal medicine, more and more researchers are interested in the exploitation of novel anticancer components in herbs. Ginsenoside Rg3, the major active component of ginseng has high. Studies have indicated its suppressive effects on the angiogenesis in Lewis cancer (Lee et al, 2009), breast cancer (Zhang et al, 2008) and on invasion and metastasis of intestinal adenocarcinomas and B16 melenoma (Liu et al, 2004; Mochizuki et al, 1995; Iishi et al, 2004) as well as proliferation of prostate cancer cells (Kim et al, 2004; Keum et al, 2003). The results demonstrated that this method was more effective in the suppression of tumor growth than conventional therapy.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
